Philip Morris still has a long way to go before it sells its last pack, Olczak sees the launch of IQOS in the US and a surge in Zyn sales as an opportunity to step in the right direction.

Shares of Philip Morris International Inc. extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the marketing of 20 of the tobacco company’s Zyn nicotine ...

Organic net revenue growth for 2025 is targeted at 6-8%, supported by strong growth in smoke-free categories and resilient combustibles. Adjusted diluted EPS is expected to range between $7.04 and ...

Reports Q4 revenue $9.7B, consensus $9.44B. “2024 was a remarkable year for PMI. We delivered very strong full-year results driven by the ...

Philip Morris International, Inc. is a holding company, which engages in the business of delivering a smoke-free future and evolving a portfolio for the long term to include products outside of ...

Philip Morris still has a long way to go before it sells its last pack, Olczak sees the launch of IQOS in the U.S. and a surge in Zyn sales as an opportunity to step in the right direction.

Philip Morris International shares edged up slightly after the Food and Drug Administration authorized marketing for 20 Zyn nicotine-pouch products. The stock rose about 1%, to $119.40 ...

Philip Morris' impressive Q3 results highlight robust performance in both core and reduced-risk products. Read why I remain ...

Philip Morris International Inc. (PM)'s share was trading at $119.80 as of Jan 16 th. PM’s trailing and forward P/E were 19.02 and 17.24 respectively according to Yahoo Finance.

Philip Morris International Inc. PM has been making significant strides toward a smoke-free future. With a strong pricing strategy, innovative smoke-free products and disciplined cost-saving ...